IFNG and non-small cell lung carcinoma: In line with this, NSCLC, ESCC, CRC, and HCC patients with low TIF-IFN-γ levels showed higher CD133 and Vimentin expression, as well as increased tumor stemness-related and EMT-related gene expression.